Novartis: This Big Pharma Giant Could Be a Sleep‑at‑Night Core Holding for Decades
Werte in diesem Artikel
Novartis (NYSE: NVS) is a major Swiss drug company with a market capitalization of over $300 billion. Its focus areas are extensive, spanning oncology, immunology, neuroscience, respiratory care, and cardiovascular, renal, and metabolic diseases. With a strong operating history and a diversified business,The pharmaceutical giant could be an attractive stock for more conservative investors. Let's dive in and take a closer look to see why.Novartis is one of the world's largest healthcare companies. That alone doesn't make it worth buying, but it speaks to the scale of the business and its historical success. A company doesn't achieve this level of scale and industry dominance by accident. Management is doing something right, and the drugmaker has been operating at a high level for years.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Ausgewählte Hebelprodukte auf :be
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf :be
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: MotleyFool